Back
Monopar Therapeutics Stock Price Chart
![](/images/offers/ims/large/offer13.jpg)
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
MNPR
Monopar Therapeutics
Last Price:
$42.34
Seasonality Move:
-18.4%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer9.jpg)
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bearish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.23 | Sell |
20-day SMA: | 42.63 | Buy |
50-day SMA: | 31.85 | Buy |
200-day SMA: | 12.72 | Buy |
8-day EMA: | 46.52 | Sell |
20-day EMA: | 42.49 | Buy |
50-day EMA: | 33.84 | Buy |
200-day EMA: | 17.46 | Buy |
Monopar Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.09 | Buy |
Relative Strength Index (14 RSI): | 54.79 | Buy |
Chaikin Money Flow: | 42632 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.73 - 48.15) | Buy |
Bollinger Bands (100): | (9.13 - 35.11) | Buy |
Monopar Therapeutics Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 43.10 while MNPR 8-day simple moving average is 48.23, which is a Sell signal.
-
The stock price of MNPR is 43.10 while Monopar Therapeutics 20-day SMA is 42.63, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 31.85 while MNPR share price is 43.10, making it a Buy technically.
-
MNPR stock price is 43.10 and Monopar Therapeutics 200-day simple moving average is 12.72, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
62
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a BuyThe current Monopar Therapeutics [MNPR] share price is $43.10. The Score for MNPR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
227.5M
Price in USD:
43.10
Share Volume:
57.5K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.70
Buy
62
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 43.10 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 43.10 while MNPR 8-day exponential moving average is 46.52, which is a Sell signal.
-
The stock price of MNPR is 43.10 while Monopar Therapeutics 20-day EMA is 42.49, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 33.84 while MNPR share price is 43.10, making it a Buy technically.
-
MNPR stock price is 43.10 and Monopar Therapeutics 200-day simple moving average is 17.46, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is 5.09, suggesting Monopar Therapeutics is a Buy
-
Monopar Therapeutics Relative Strength Index (RSI) is 54.79, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is (30.73 - 48.15), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (9.13 - 35.11), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.